Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-08-02

FDA Approved: PHENELZINE SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for phenelzine sulfate, an MAOI antidepressant, expanding regulatory approval for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenelzine sulfate (Phenelzine sulfate)

Snippet

SUPPL AP for PHENELZINE SULFATE (PHENELZINE SULFATE)